Shao-Zhao Zhang (Shaozhao Zhang)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Atrial Fibrillation

St Segment Elevation Myocardial Infarction

Coronary Artery Disease

Top Venues

Journal of the American Heart Association

ESC heart failure

This page only lists publications with an associated author ORCID identifier.

Publications

Yuhui Lai, Xingfeng Xu, Shao-Zhao Zhang, Rihua Huang, Yiquan Huang, Xiangbin Zhong, Zhenyu Xiong, Yifen Lin, Huimin Zhou, Yue Guo, Xin-Xue Liao, Yuedong Ma, Xiaodong Zhuang
New Insights into Rate Control: Time in Target Range of Resting Heart Rate and Major Adverse Outcomes in Atrial Fibrillation. Global heart 19 (1) (2024)
Yuhui Lai, Xingfeng Xu, Shao-Zhao Zhang, Rihua Huang, Yiquan Huang, Xiangbin Zhong, Zhenyu Xiong, Yifen Lin, Huimin Zhou, Yue Guo, Xin-Xue Liao, Yuedong Ma, Xiaodong Zhuang
New Insights into Rate Control: Time in Target Range of Resting Heart Rate and Major Adverse Outcomes in Atrial Fibrillation. Global heart 19 (1) (2024)
Yuhui Lai, Xingfeng Xu, Shao-Zhao Zhang, Rihua Huang, Yiquan Huang, Xiangbin Zhong, Zhenyu Xiong, Yifen Lin, Huimin Zhou, Yue Guo, Xin-Xue Liao, Yuedong Ma, Xiaodong Zhuang
New Insights into Rate Control: Time in Target Range of Resting Heart Rate and Major Adverse Outcomes in Atrial Fibrillation. Global heart 19 (1) (2024)
Zhuoshan Huang, Xiao-Dong Zhuang, Shao-Zhao Zhang, Yiquan Huang, Lianxiong Yuan, Aiwen Lin, Leile Tang, Zhenyu Xiong, Odong Christopher, Yang Chen, Bingyuan Wu, Yesheng Ling, Suhua Li, Qiang Jie, Longgen Xiong, Xiaoxian Qian, Xin-Xue Liao, Jinlai Liu
Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trial. BMJ open 13 (7) (2023)
Hui-Min Zhou, Rong-Jian Zhan, Xuanyu Chen, Yi-Fen Lin, Shao-Zhao Zhang, Huigan Zheng, Xueqin Wang, Meng-Ting Huang, Chao-Guang Xu, Xin-Xue Liao, Ting Tian, Xiao-Dong Zhuang
Targeting efficacy of spironolactone in patients with heart failure with preserved ejection fraction: the TOPCAT study. ESC heart failure (2022)
Yongqiang Fan, Gaoxing Zhang, Zheng-Zhi-Peng Zhang, Shao-Zhao Zhang, Menghui Liu, Yifen Lin, Yiquan Huang, Xiangbin Zhong, Xiao-Dong Zhuang, Xin-Xue Liao
Critical Appraisal of Guidelines for Antithrombotic Therapy in Atrial Fibrillation Post-Percutaneous Coronary Intervention. Global heart 17 (1) (2022)
Menghui Liu, Xiaohong Chen, Shao-Zhao Zhang, Junfan Lin, Lichun Wang, Xin-Xue Liao, Xiao-Dong Zhuang
Assessment of Visit-to-Visit Blood Pressure Variability in Adults With Optimal Blood Pressure: A New Player in the Evaluation of Residual Cardiovascular Risk? Journal of the American Heart Association 11 (9) (2022)
Yiquan Huang, Huimin Zhou, Shao-Zhao Zhang, Xiangbin Zhong, Yifen Lin, Zhenyu Xiong, Menghui Liu, Aili Yimamu, Odong Christopher, Ziwei Zhou, Xiao-Dong Zhuang, Xin-Xue Liao
Mid- to Late-Life Time-Averaged Cumulative Blood Pressure and Late-Life Retinal Microvasculature: The ARIC Study. Journal of the American Heart Association 11 (15) (2022)
Rihua Huang, Yifen Lin, Menghui Liu, Zhenyu Xiong, Shao-Zhao Zhang, Xiangbin Zhong, Xiaomin Ye, Yiquan Huang, Xiao-Dong Zhuang, Xin-Xue Liao
Time in Target Range for Systolic Blood Pressure and Cardiovascular Outcomes in Patients With Heart Failure With Preserved Ejection Fraction. Journal of the American Heart Association 11 (7) (2022)
Shao-Zhao Zhang, Huimin Zhou, Xiaodong Zhuang, Daya Yang, Xiuting Sun, Xiangbin Zhong, Xiaoyu Lin, Xun Hu, Yiquan Huang, Xinxue Liao, Zhimin Du
Critical appraisal of guidelines for coronary artery disease on dual antiplatelet therapy: More consensus than controversies. Clinical cardiology 42 (12) (2019)